Trial intelligence / Profile preview

Autologous Adipose Tissue Derived MSCs in Rotator Cuff Disease

NCT02474342Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Jul 2015
Primary completion
Nov 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 1, open-label trial of JOINTSTEM in rotator cuff disease (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Shoulder Pain and Disability Index at 24 weeks. Started Jul 2015; status: completed.

02

Drugs

JOINTSTEM
03

Conditions

rotator cuff disease

Beyond the preview

Go deeper on NCT02474342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02474342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call